000 01663 a2200457 4500
005 20250517004440.0
264 0 _c20160321
008 201603s 0 0 eng d
022 _a1873-3476
024 7 _a10.1016/j.ijpharm.2014.10.032
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCohrs, Björn
245 0 0 _aIn vivo SPECT imaging of [¹²³I]-labeled pentamidine pro-drugs for the treatment of human African trypanosomiasis, pharmacokinetics, and bioavailability studies in rats.
_h[electronic resource]
260 _bInternational journal of pharmaceutics
_cDec 2014
300 _a167-75 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aBiological Availability
650 0 4 _aBlood-Brain Barrier
_xmetabolism
650 0 4 _aBrain
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPentamidine
_xanalogs & derivatives
650 0 4 _aProdrugs
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSuccinates
_xpharmacokinetics
650 0 4 _aTime Factors
650 0 4 _aTissue Distribution
650 0 4 _aTomography, Emission-Computed, Single-Photon
_xmethods
650 0 4 _aTrypanocidal Agents
_xpharmacokinetics
650 0 4 _aTrypanosomiasis, African
_xdrug therapy
700 1 _aZhao, Yi
700 1 _aLützen, Ulf
700 1 _aCulman, Juraj
700 1 _aClement, Bernd
700 1 _aZuhayra, Maaz
773 0 _tInternational journal of pharmaceutics
_gvol. 477
_gno. 1-2
_gp. 167-75
856 4 0 _uhttps://doi.org/10.1016/j.ijpharm.2014.10.032
_zAvailable from publisher's website
999 _c24410130
_d24410130